Product Code: ETC6189466 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australia Proton Pump Inhibitors (PPIs) Market continues to be driven by the high incidence of gastroesophageal reflux disease (GERD), peptic ulcers, and other acid-related disorders. These drugs are commonly used as over-the-counter and prescription medications, making them widely accessible to consumers. However, growing awareness about the long-term side effects of prolonged PPI use is influencing prescribing habits, and alternatives like H2 blockers are also gaining popularity, creating competitive pressure within the segment.
The proton pump inhibitors (PPI) market in Australia is stabilizing as the awareness of gastrointestinal disorders such as GERD (gastroesophageal reflux disease) and ulcers increases. However, the trend is also shaped by growing scrutiny regarding the long-term use of PPIs due to potential side effects. As a result, there`s a gradual shift towards more regulated prescribing practices and the development of more targeted therapies, such as potassium-competitive acid blockers (P-CABs), which could emerge as alternatives.
The Proton Pump Inhibitors (PPI) Market in Australia faces challenges such as increasing concerns about long-term usage of PPIs and the potential for adverse side effects, including bone fractures, kidney disease, and vitamin B12 deficiency. Additionally, market growth is being hindered by the rise of over-the-counter medications, which are more affordable but may not be as effective for certain conditions. The emergence of generic alternatives has led to intense competition and pricing pressure, challenging the profitability of branded PPI manufacturers.
Driven by increasing incidences of gastrointestinal disorders and over-the-counter medication preferences, the proton pump inhibitors (PPI) market offers stable investment prospects. There is room for innovation in long-acting and fast-dissolving formulations. Regulatory approvals for generic versions and partnerships with pharmacy chains can bolster market share. Consumer awareness campaigns can also drive product differentiation.
Proton pump inhibitors (PPIs) are classified as either prescription or over-the-counter drugs and are regulated by the TGA. Government policies under the Pharmaceutical Benefits Scheme (PBS) ensure subsidized access to PPIs. The government also monitors use through prescription guidelines to reduce overuse and associated health risks.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Proton Pump Inhibitors Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Proton Pump Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Proton Pump Inhibitors Market - Industry Life Cycle |
3.4 Australia Proton Pump Inhibitors Market - Porter's Five Forces |
3.5 Australia Proton Pump Inhibitors Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
4 Australia Proton Pump Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Proton Pump Inhibitors Market Trends |
6 Australia Proton Pump Inhibitors Market, By Types |
6.1 Australia Proton Pump Inhibitors Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Proton Pump Inhibitors Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Australia Proton Pump Inhibitors Market Revenues & Volume, By OTC Drugs, 2021- 2031F |
6.1.4 Australia Proton Pump Inhibitors Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
7 Australia Proton Pump Inhibitors Market Import-Export Trade Statistics |
7.1 Australia Proton Pump Inhibitors Market Export to Major Countries |
7.2 Australia Proton Pump Inhibitors Market Imports from Major Countries |
8 Australia Proton Pump Inhibitors Market Key Performance Indicators |
9 Australia Proton Pump Inhibitors Market - Opportunity Assessment |
9.1 Australia Proton Pump Inhibitors Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10 Australia Proton Pump Inhibitors Market - Competitive Landscape |
10.1 Australia Proton Pump Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 Australia Proton Pump Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |